Screener
Perspective Therapeutics CATX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Perspective Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:34 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342512
FAQ
- What is Perspective Therapeutics's current ratio?
- Perspective Therapeutics (CATX) reported current ratio of 6.6× in Q2 2026.
- How has Perspective Therapeutics's current ratio changed year-over-year?
- Perspective Therapeutics's current ratio decreased by 56.2% year-over-year, from 15.1× to 6.6×.
- What is the long-term trend for Perspective Therapeutics's current ratio?
- Over 5 years (2020 to 2025), Perspective Therapeutics's current ratio has grown at a -10.9% compound annual growth rate (CAGR), from 9.2× to 5.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Perspective Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude